1 |
Bezafibrat |
- |
- |
- |
- |
093 [1] 93 💬 |
2 |
Bezafibrat genericon retard 400 mg |
- |
- |
- |
- |
093 [1] 93 💬 |
3 |
Bezafibrate |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
020 [6] 20, 93, 94, 160, 316, 324 💬 |
4 |
Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour udca therapy |
Bezafibrate |
[2] D00734 D00734, D01366 D01366 💬 |
NR1H4 [2] NR1H4, PPARA 💬 |
Adipocytokine signaling pathway [9] Adipocytokine signaling pathway, Bile secretion, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
094 [1] 94 💬 |
5 |
Bezafibrate (drug) |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
316 [1] 316 💬 |
6 |
Bezafibrate (inn 3968) |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
324 [1] 324 💬 |
7 |
Bezafibrate 200 mg |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
8 |
Bezafibrate 400 mg |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
9 |
Bezafibrate ir |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
10 |
Bezafibrate sr |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
11 |
Bezafibrate, beza, bzf, bezalip |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |
12 |
Bezafibrate, beza, bzf, bezalip mono |
Bezafibrate |
[1] D01366 D01366 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
093 [1] 93 💬 |